Divergent Parkinson’s Disease Burden Trajectories in China and the United States: Rising Incidence in China and Rising Mortality in the United States, 1990–2033
Background: Parkinson’s disease (PD) is a growing public health challenge in ageing societies. China and the United States, as the world’s largest developing and developed economies, represent distinct stages of demographic and epidemiological transition and differ substantially in environmental exposures and healthcare systems. We compared temporal changes in PD burden in these two countries from 1990 to 2023, examined smoking-related population attributable fractions in GBD 2023, and projected disease burden through 2033. Methods: Data on PD incidence, prevalence, deaths, disability-adjusted life years (DALYs), and age-standardized rates (ASRs) were extracted from the GBD 2023 database. Temporal trends were assessed using percentage change and estimated annual percentage change (EAPC). Age-specific patterns were examined using stratified visual analyses. We also fitted autoregressive integrated moving average (ARIMA) models with Box-Cox transformation to project age-standardized incidence, prevalence, mortality, and DALY rates from 2024 to 2033. Results: From 1990 to 2023, the absolute number of people living with PD increased markedly in both countries, rising from 781,300 to 3,445,700 in China and from 565,900 to 998,300 in the United States. After age standardization, a divergent pattern emerged. In China, incidence increased whereas mortality declined (EAPC for mortality = -0.90). In the United States, incidence remained broadly stable whereas mortality increased (EAPC = 1.67). Age-specific analyses showed that PD burden became increasingly concentrated in older adults in both countries, with the greatest burden observed in those aged 70 years and above. Smoking was the only risk factor with quantifiable PD-specific attribution data for both countries. Its PAF estimates for deaths and DALYs were negative in both settings, most prominently in Chinese males, whose negative DALY PAF was more than 10 times that in Chinese females. Forecasts to 2033 suggested modest declines in age-standardized mortality and DALYs in China, but increasing age-standardized prevalence, mortality, and DALY burden in the United States. Conclusion: China and the United States showed markedly divergent age-standardized PD burden trajectories despite increasing absolute burden in both countries. Smoking showed negative attribution in both populations, and forecasts to 2033 suggest relatively stable trends in China but further increases in prevalence and severity-related burden in the United States. These negative smoking PAFs are consistent with the widely reported inverse epidemiological association between smoking and PD, but do not imply a causal protective effect.
Authors
- 莫雪妮
- Peizhen Wu
- Fei He
- Renda He
- Peiying Lu
- Wei Ma
- Yibao Yang
- Tingting Xie
Publication Details
- Journal
- Neuroepidemiology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1159/ned/adwag086
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00